“Positive results from large clinical study on newborns, aquire of strategic IP assets and a reinforced board lay the foundation for successful commercial launch of the company’s medical device for continuous lung monitoring.” CEO Hanna Sjöström
PM and Q2 report (in Swedish): Neola Medical Q2 report 2022